What is Azathioprine?
Category: Prescription Drugs
Most popular types: Imuran Azapress Imurel Show all
Azathioprine is an immunosuppressant agent used to manage active rheumatoid arthritis and as an adjunctive therapy for the prevention of rejection of kidney transplants.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Systemic lupus erythematosus | 1995 | 96 | |
| Crohn's disease | 662 | 55 | |
| Idiopathic pulmonary fibrosis | 265 | 25 | |
| Prevent organ rejection | 241 | 31 | |
| Ulcerative colitis | 163 | 24 | |
| Autoimmune hepatitis | 151 | 15 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 73 | |
| Moderate | 87 | |
| Mild | 80 | |
| None | 148 |
Why patients stopped taking Azathioprine
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Doctor's advice | 134 | |
| Side effects too severe | 124 | |
| Did not seem to work | 93 | |
| Other | 54 | |
| Course of treatment ended | 30 | |
| Personal research | 12 | |
| Change in health plan coverage | 8 | |
| Expense | 4 |
Duration
Stopped taking Azathioprine
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 61 | |
| 1 - 6 months | 71 | |
| 6 months - 1 year | 44 | |
| 1 - 2 years | 51 | |
| 2 - 5 years | 40 | |
| 5 - 10 years | 30 | |
| 10 years or more | 28 |
What people switch to and from
Patients started taking Azathioprine after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Methotrexate (Apo-Methotrexate) | 43 | |
| Prednisone (Prednisone Intensol) | 22 | |
| Hydroxychloroquine (Plaquenil) | 17 | |
| Mycophenolate mofetil (CellCept) | 14 | |
| Mesalamine (Pentasa) | 9 |
Patients stopped taking Azathioprine and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Mycophenolate mofetil (CellCept) | 34 | |
| Methotrexate (Apo-Methotrexate) | 16 | |
| Adalimumab (Humira) | 10 | |
| Hydroxychloroquine (Plaquenil) | 10 | |
| Belimumab (Benlysta) | 8 |
Last updated: